sperabillin A

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesperabillin A
Drug Alias Namesperabillin Dantibiotic TAN-749Asperabillin Csperabillin BTAN-749A +[7
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasmsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasmsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A